Cargando…
The lncRNA CASC2 Modulates Hepatocellular Carcinoma Cell Sensitivity and Resistance to TRAIL Through Apoptotic and Non-Apoptotic Signaling
The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been widely concerned as a tumor therapy because of its ability of selective triggering cancer cell apoptosis; nevertheless, hepatocellular carcinoma (HCC) exhibits acquired resistance to TRAIL-induced apoptosis....
Autores principales: | Sun, Jichun, Xu, Hongbo, Lei, Zhao, Li, Zhiqiang, Zhu, Hongwei, Deng, Zhen, Yu, Xiao, Jin, Xiaoxin, Yang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823509/ https://www.ncbi.nlm.nih.gov/pubmed/35145900 http://dx.doi.org/10.3389/fonc.2021.726622 |
Ejemplares similares
-
CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3
por: Jin, Xiaoxin, et al.
Publicado: (2018) -
The Prognostic Value of a lncRNA Risk Model Consists of 9 m6A Regulator-Related lncRNAs in Hepatocellular Carcinoma (HCC)
por: Deng, Zhen, et al.
Publicado: (2023) -
LncRNA CASC11 Promotes Hepatocellular Carcinoma Progression via Upregulation of UBE2T in a m(6)A-Dependent Manner
por: Chen, Fei, et al.
Publicado: (2021) -
Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019) -
Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)